CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration

Journal of Neurology

Volumn 256, Issue 8, 2009, Pages 1379-1381

  Villa, Chiara ^a   Venturelli, Eliana ^a   Fenoglio, Chiara ^a   Clerici, Francesca ^b   Marcone, Alessandra ^c   Benussi, Luisa ^d   Ghidoni, Roberta ^d   Gallone, Salvatore ^e   Cortini, Francesca ^a   Scalabrini, Diego ^a   Serpente, Maria ^a   Binetti, Giuliano ^d   Cappa, Stefano ^c   Mariani, Claudio ^b   Rainero, Innocenzo ^e   Bresolin, Nereo ^a   Scarpini, Elio ^a   Galimberti, Daniela ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

Author keywords

Alzheimer's disease; CCL8 MCP 2; Frontotemporal lobar degeneration; Risk factor

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 2;

AGED; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; CHEMOKINE CCL8; DEMENTIA; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 68349141062     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5138-y     Document Type: Article

References (9)

1. AD Luster 1998 Chemokines-chemotactic cytokines that mediate inflammation N Engl J Med 338 436 445
2. D Galimberti N Schoonenboom P Scheltens C Fenoglio F Bouwman E Venturelli I Guidi MA Blankenstein N Bresolin E Scarpini 2006 Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease Arch Neurol 63 4 538 543
3. D Galimberti N Schoonenboom P Scheltens C Fenoglio E Venturelli YA Pijnenburg N Bresolin E Scarpini 2006 Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration Neurology 66 1 146 147
4. W Kelder JC [tmp] McArthur T Nance-Sproson D [tmp] McClernon DE Griffin 1998 β-Chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia Ann Neurol 44 831 835
5. Galimberti D, Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A, Benussi L, Cortini F, Scalabrini D, Perini L, Restelli I, Binetti G, Cappa S, Mariani C, Bresolin N, Scarpini E (2009) MCP-1 A-2518G polymorphism: effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels. J Alzheimer's Dis 17(1)
6. P Proost A Wuyts J Van Damme 1996 Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1 J Leukoc Biol 59 67 74
7. J Wang D Gabuzda 2006 Reconstitution of human immunodeficiency virus-induced neurodegeneration using isolated populations of human neurons, astrocytes and microglia and neuroprotection mediated by insulin-line growth factor J Neurovirol 12 472 491
8. G [tmp] McKhann D Drachman M Folstein R Katzman D Price EM Stadlan 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 939 944
9. D Neary JS Snowden L Gustafson 1998 Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria Neurology 51 1546 1554